References:
- Ross JR, Puga TA, & Philbeck TE. Longitudinal dialysis adequacy
and clinical performance
of the VectorFlow hemodialysis catheter: a prospective study. J
Vasc Access.
2017;18(6):492-497. Study sponsored by Teleflex. Ross JR was
formerly a paid consultant of
Teleflex. Puga TA and Philbeck TE are employees of Teleflex.
- Data on file at Teleflex. Test data may not be indicative of
clinical performance.
- Nobili M, Sheriff J, Morbiducci U, et al. Platelet activation due to
hemodynamic shear
stresses: damage accumulation model and comparison to in-vitro
measurements. ASAIO J.
2008;54(1):64-72.
- Data on file at Teleflex. Test data may not be indicative of
clinical performance.
- Clark TWI, Isu G, Gallo D, et al. Comparison of symmetric
hemodialysis catheters using
computational fluid dynamics. J Vasc Interv Radiol.
2015;26(2):252-259. Data on file
at Teleflex. Computer modeling may not be indicative of clinical
performance. Timothy Clark,
MD, is a paid consultant and receives royalty payments from Teleflex
or its affiliates for the
Arrow-Clark VectorFlow Chronic Hemodialysis Catheter.
- National Kidney Foundation. KDOQI clinical practice guidelines and
clinical practice
recommendations. Guideline 7: Prevention and treatment of catheter
and port complications.
2006 update. Am J Kidney Dis. 2006;48:1-322.
The Arrow-Clark™
VectorFlow® Antegrade
Catheter is indicated for use in attaining long-term vascular access for
hemodialysis and
apheresis. The Arrow-Clark™ VectorFlow®
Antegrade Catheter is
inserted percutaneously and is preferentially placed into the internal
jugular (IJ) vein.
Alternately, this catheter may be inserted into the subclavian vein although
the jugular vein is
the preferred site. Catheters greater than 40 cm are intended for femoral
vein insertion. The
Arrow-Clark™ VectorFlow® Antegrade Catheter
is intended for use in
adult patients.
The Arrow-Clark™ VectorFlow®
Retrograde Catheter is indicated for
use in attaining long-term vascular access for hemodialysis and apheresis.
The
Arrow-Clark™ VectorFlow® Retrograde Catheter
is inserted
percutaneously and is preferentially placed into the internal jugular (IJ)
vein. Alternately, this
catheter may be inserted into the subclavian vein although the jugular vein
is the preferred site.
Catheters greater than 40 cm are intended for femoral vein insertion. The
Arrow-Clark™ VectorFlow® Retrograde Catheter
is intended for use
in adult patients.
Refer to the Instructions for Use for a complete listing of the
indications, contraindications,
warnings and precautions. Information in this material is not a substitute
for the product
Instructions for Use.
CAUTION: Federal (USA) law restricts this device to sale by or on
the order of a physician.
Not all products are available in all regions. Please contact
customer service to confirm
availability in your region.
VectorFlow is a registered trademark of Aegis Medical Technologies
LLC.
Teleflex, the Teleflex logo and Arrow-Clarke are trademarks or
registered trademarks of Teleflex
Incorporated or its affiliates, in the U.S. and/or other countries.
MC-004319 Rev 2
Revised: 09/2021.